Advertisement

Topics

Search Results for "Breast Pap Test Trial"

19:48 EDT 16th August 2017 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps

OncoDEEP

At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

A simple breath test could be the next step in diagnosing breast cancer

OU and Mercy test new models in largest breast cancer clinical trial in Oklahoma

(University of Oklahoma) A University of Oklahoma and Mercy Hospital Oklahoma City research team is set to begin the largest breast cancer clinical trial ever performed in Oklahoma. The team has devel...

New tests offer personalised treatment for late-stage breast cancer patients – Sky News

Sky NewsNew tests offer personalised treatment for late-stage breast cancer patientsSky NewsA new blood test detects changes in 13 different genes which are closely linked to the progress of advanced-...

[Articles] Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

We showed non-inferiority of partial-breast and reduced-dose radiotherapy compared with the standard whole-breast radiotherapy in terms of local relapse in a cohort of patients with early breast cance...

Multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy

A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal ...

Blood test offers improved breast cancer detection new tool to reduce use of breast biopsy

(Provista Diagnostics) Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results & potentially reduce biopsies up to 67%.

Blood test offers improved breast cancer detection tool to reduce use of breast biopsy

(Provista Diagnostics) A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.

Breast Cancer Liquid Biopsy Study Validates Test as Improved Diagnostic Tool

Noninvasive molecular diagnostic techniques are not only the latest cutting-edge technique to help clinicians improve disease prognosis—they are proving to be an essential element for the continued ...

Matching PubMed Articles

First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.

To report early outcome analysis of a prospective institutional phase 2 trial of weekly hypofractionated breast irradiation (WHBI) for patients undergoing breast-conserving surgery (BCS).

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.

SUPREMO is a phase 3 randomised trial evaluating radiotherapy post-mastectomy for intermediate-risk breast cancer. 1688 patients were enrolled from 16 countries between 2006 and 2013. We report the re...

Human Breast Phantoms: Test Beds for the Development of Microwave Diagnostic and Therapeutic Technologies.

Over the past two decades, there has been enormous growth in research activity for microwave diagnostic and therapeutic technologies that target the breast. The clinical need for new tools in the brea...

Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials.

We aim to assess any association between study and self-reported conflict of interest (COI) or trial sponsorship in breast cancer radiation clinical trials.

Trial 1 Versus Trial 2 of the Test of Memory Malingering: Evaluating Accuracy Without a "Gold Standard".

This study examines the accuracy of the Test of Memory Malingering (TOMM), a frequently administered measure for evaluating effort during neurocognitive testing. In the last few years, several authors...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement